hepat
c
viru
hcv
infect
import
global
public
health
problem
approxim
million
peopl
current
infect
hcv
alarm
number
new
infect
occur
annual
preval
hepat
c
vari
significantli
worldwid
impos
import
burden
highli
endem
countri
hcv
infect
commonli
associ
chronic
liver
diseas
frequent
result
advanc
stage
cirrhosi
hepatocellular
carcinoma
hcc
follow
year
silent
infect
hcv
singlestrand
positivesens
envelop
flaviviru
viral
rna
genom
kb
length
contain
singl
open
read
frame
encod
larg
polyprotein
polyprotein
process
viral
host
proteas
result
three
structur
protein
seven
nonstructur
protein
figur
hcv
molecular
evolut
play
import
role
viru
transmiss
dictat
mani
way
outcom
diseas
therapi
base
nucleotid
variabl
viral
genom
seven
hcv
genotyp
multipl
subtyp
recogn
figur
genotyp
exhibit
characterist
distribut
genotyp
distribut
worldwid
genotyp
mainli
found
africa
genotyp
endem
asia
high
mutat
rate
characterist
hcv
replic
result
high
degre
intrahost
genet
divers
molecular
plastic
hcv
allow
rapid
rearrang
intrahost
viral
popul
differ
select
pressur
remark
genet
variabl
one
main
factor
prevent
develop
success
vaccin
molecular
surveil
hepat
c
utmost
import
identif
hcv
transmiss
network
molecular
surveil
critic
compon
hcv
outbreak
investig
track
infect
necessari
identif
sourc
infect
accur
identif
case
associ
transmiss
network
addit
molecular
surveil
provid
import
inform
capac
hcv
lineag
caus
diseas
addit
impos
import
challeng
vaccin
develop
hcv
genet
variabl
also
repres
major
issu
establish
genet
related
case
associ
common
sourc
infect
rapidli
evolv
natur
viru
result
signific
chang
genet
makeup
viru
prevent
abil
link
case
genet
similar
howev
high
degre
genet
variabl
also
requir
track
infect
facilit
genet
related
studi
otherwis
would
hamper
present
histor
review
keyston
discoveri
propel
understand
mechan
control
hcv
transmiss
addit
discuss
recent
inform
molecular
aspect
relat
viral
spread
novel
approach
design
assess
hcv
intrahost
genet
variabl
establish
genet
related
case
final
implement
advanc
hcv
molecular
surveil
integr
compon
hepat
c
global
epidemiolog
highlight
sinc
discoveri
year
ago
studi
hcv
seen
number
cornerston
develop
improv
understand
hcvrelat
diseas
pathogenesi
figur
field
viral
hepat
initi
began
late
coin
term
infecti
serum
hepat
event
follow
discoveri
hepat
hav
hepat
b
virus
hbv
late
earli
howev
understand
hcv
infect
date
late
research
center
diseas
control
chiron
corpor
led
daniel
bradley
michael
houghton
respect
identifi
viru
sampl
experiment
infect
chimpanze
prior
identif
advent
serolog
test
hav
hbv
led
realiz
infecti
hepat
case
nona
nonb
nanbh
find
prompt
use
chimpanze
anim
model
passag
unidentifi
agent
respons
nanbh
subsequ
develop
serolog
test
detect
hcv
infect
earli
allow
screen
blood
suppli
success
prevent
transmiss
via
transfus
hcv
molecular
diverg
recogn
shortli
discoveri
viru
japanes
strain
shown
genet
distant
american
strain
subsequ
complet
sequenc
hcv
genom
allow
elucid
organ
molecular
character
viral
enzym
earli
serv
foundat
develop
success
antihcv
therapi
result
constant
reshap
antihcv
therapi
base
interferon
ifn
initi
approv
alpha
ifn
treatment
hcv
follow
licens
consensu
ifn
ribavirin
rbv
introduct
pegyl
ifn
compound
significantli
prolong
halflif
blood
increas
likelihood
sustain
virolog
respons
svr
full
recognit
degre
genet
heterogen
among
hcv
isol
achiev
result
propos
classif
hepacivirus
independ
genu
within
flavivirida
famili
repres
distant
rel
flaviviru
pestiviru
genera
importantli
fact
hcv
divers
play
import
role
interferon
ifn
base
therapi
highlight
relev
assess
genet
variabl
viral
popul
vivo
import
advanc
drug
develop
gener
human
hepatoma
cell
line
capabl
replic
hcv
year
import
discoveri
report
sever
group
especi
relat
character
viral
protein
role
hcv
replic
addit
character
sever
cellular
receptor
entri
factor
report
initi
releas
first
next
gener
sequenc
ng
commerci
platform
complet
revolution
field
genet
howev
initi
studi
report
use
ng
approach
assess
hcv
intrahost
genet
variat
emerg
late
sinc
time
wealth
inform
gener
use
ng
address
multitud
issu
relat
hcv
transmiss
challeng
resid
studi
whole
genom
wg
genet
variat
still
repres
daunt
task
studi
hcv
molecular
evolut
sinc
reconstruct
origin
haplotyp
ng
data
difficult
ge
et
al
report
strong
associ
polymorph
promot
region
gene
also
known
antivir
respons
base
ifn
subsequ
work
conduct
group
confirm
relationship
genotyp
sustain
viral
respons
svr
relev
report
underst
result
extens
work
human
genet
becam
import
compon
studi
pathogenesi
hcvrelat
diseas
arriv
second
gener
directact
antivir
daa
result
improv
svr
revolut
field
antihcv
therapi
despit
develop
drug
resist
initi
proteas
inhibitor
pi
telaprevir
boceprevir
undoubtedli
possess
advantag
dual
ifnrbv
treatment
success
drug
subsequ
eclips
licens
simeprevir
sofosbuvir
field
hcv
therapi
rapidli
evolv
result
larg
number
new
antivir
drug
current
evalu
advanc
clinic
trial
prevent
hcv
infect
hamper
slow
develop
promis
vaccin
candid
phase
two
differ
vaccin
trial
complet
test
primeboost
regimen
candid
develop
glaxosmithklin
preliminari
studi
chimpanze
model
also
perform
importantli
conserv
epitop
hcv
genotyp
success
identifi
suggest
potenti
crossgenotyp
protect
prime
vaccin
follow
boost
modifi
vaccinia
viru
current
evalu
phase
iii
trial
goal
prevent
persist
idu
high
risk
infect
hcv
transmiss
dynam
process
primarili
occur
via
parenter
rout
especi
unsaf
inject
significantli
facilit
viru
spread
time
initi
spread
hcv
western
countri
popul
dynam
epidem
indirectli
infer
current
evid
support
recent
spread
howev
lack
sampl
prior
second
world
war
hinder
abil
reconstruct
hcv
epidem
vertic
sexual
transmiss
contribut
littl
hcv
spread
restrict
hcv
transmiss
primarili
parenter
rout
implic
unsaf
inject
ie
inadequ
medic
treatment
largescal
vaccin
program
blood
transfus
inject
drug
use
main
vehicl
hcv
transmiss
limit
inform
avail
transmiss
hcv
prior
invent
inject
howev
cultur
tradit
tattoo
scarif
like
play
import
role
spread
hcv
hcv
intrahost
popul
frequent
exist
ensembl
genet
distinct
close
relat
variant
analysi
hcv
intrahost
genet
variat
basi
genet
related
epidemiolog
studi
well
identif
drug
resist
mutat
instanc
genet
related
might
demonstr
consensu
sequenc
viral
subgenom
region
hcv
outbreak
investig
commonli
requir
much
deeper
analysi
infect
viral
popul
rapid
hcv
intrahost
popul
diverg
significantli
affect
genet
related
studi
molecular
epidemiolog
link
lost
relat
case
rel
short
period
time
figur
therefor
use
longer
subgenom
region
might
help
allevi
issu
molecular
mechan
shape
evolut
hcv
quit
divers
upon
transmiss
hcv
undergo
seri
event
affect
architectur
viral
popul
figur
step
taken
hcv
throughout
infect
process
highli
complex
depend
fluctuat
complex
size
intrahost
popul
hcv
transmiss
event
character
genet
bottleneck
inflict
strong
select
pressur
acut
infect
inde
hcv
genet
bottleneck
intens
follow
transmiss
variant
abl
establish
infect
new
host
subsequ
genet
drift
commonli
take
place
main
forc
drive
molecular
evolut
hcv
earli
stage
acut
phase
result
strong
founder
effect
later
stage
hcv
infect
extent
genet
drift
significantli
reduc
allow
larg
viral
popul
size
come
promin
chronic
case
lesser
degre
genet
recombin
also
affect
overal
hcv
genet
heterogen
hcv
genet
recombin
rare
mainli
due
exclus
superinfect
howev
despit
limit
hcv
recombin
natur
occur
intergenotyp
intragenotyp
intrastrain
hcv
recombin
report
thu
hcv
recombin
might
import
implic
clinic
epidemiolog
studi
stage
hcv
infect
also
propos
hypothesi
suggest
chronic
infect
hcv
attempt
reach
settlement
stage
character
viral
popul
undergo
strong
neg
select
journey
involv
complex
process
includ
tempor
variat
attain
increment
chang
commun
random
mutat
fluctuat
frequenc
coexist
viral
subpopul
conjunct
factor
constantli
reshap
architectur
viral
popul
stage
like
affect
hcv
transmiss
differ
viral
variant
like
possess
differ
degre
transmiss
avail
differ
time
point
cours
infect
despit
complex
mean
use
hcv
evolv
advers
microenviron
genet
related
success
establish
mani
instanc
transmiss
occur
rel
recent
addit
time
infect
establish
related
depend
degre
diverg
extern
factor
histori
antivir
therapi
significantli
alter
natur
cours
hcv
evolut
hcv
transmiss
network
difficult
recogn
numer
reason
long
incub
period
characterist
asymptomat
natur
acut
hcv
infect
make
identif
case
rather
challeng
task
hcv
transmiss
difficult
link
correspond
sourc
infect
intrahost
viral
popul
often
genet
relat
seldom
ident
importantli
branch
phylogenet
analys
deriv
genet
related
studi
alway
correspond
transmiss
event
particularli
case
individu
belong
transmiss
network
sampl
figur
thu
local
epidem
sequenc
cluster
togeth
absenc
direct
transmiss
hcv
evolut
also
affect
preexist
liver
condit
infect
virus
also
pregnanc
direct
consequ
alter
immun
respons
mother
pregnanc
increas
viral
load
reduct
cell
cytotox
commonli
observ
favor
emerg
fit
strain
result
impair
antivir
respons
mother
therefor
children
infect
perinat
might
potenti
bear
infect
fit
virus
therebi
facilit
persist
era
human
genet
expect
play
import
role
clinic
manag
infecti
diseas
hcv
infect
except
sever
studi
shown
host
genet
makeup
affect
outcom
infect
therapi
hcv
spontan
clear
host
acut
infect
individu
report
earli
function
inactiv
peripher
toler
hcvspecif
cell
respons
may
play
major
role
establish
viral
persist
dysfunct
cell
function
reactiv
sever
studi
suggest
differ
host
immun
respons
determin
viral
clearanc
inde
intens
immun
respons
dictat
least
part
host
genet
factor
howev
role
host
factor
hcv
clearanc
well
understood
differ
studi
shown
correl
hcvrelat
diseas
genet
background
host
exampl
certain
hla
allel
associ
specif
outcom
hcv
infect
result
complet
human
genom
project
develop
novel
methodolog
capabl
rapidli
assess
host
genet
background
number
diseaseassoci
gene
recent
report
consequ
mutat
gene
screen
use
assist
clinic
decis
make
process
inform
also
incorpor
heighten
surveil
number
infecti
diseas
facilit
incorpor
pharmacogenet
global
surveil
recent
sever
singl
nucleotid
polymorph
snp
immunerel
gene
associ
hcv
diseas
outcom
largescal
genet
analys
suggest
particip
differ
snp
spontan
clearanc
hcv
includ
tumor
necrosi
factor
superfamili
member
tank
traf
famili
member
associ
activ
hepat
viru
cellular
receptor
bind
protein
addit
snp
occur
gene
encod
tumor
necrosi
factor
alpha
also
propos
particip
hcv
clearanc
particularli
subject
african
origin
import
cytokin
produc
primarili
macrophag
particip
induct
apoptosi
gene
regul
cellular
prolifer
interestingli
high
level
tnf
detect
serum
liver
chronic
infect
patient
snp
transform
growth
factor
tgf
also
suggest
particip
hcv
clearanc
suppressor
natur
killer
nk
cell
inhibit
product
therebi
block
prolifer
cytotox
nk
cell
moreov
dysregul
tgf
shown
involv
progress
liver
cirrhosi
hcc
multifunct
cytokin
produc
effector
nk
cell
particip
develop
helper
cell
critic
host
defens
varieti
intracellular
pathogen
includ
hcv
inhibit
hcv
replic
vitro
intrahepat
level
associ
viral
clearanc
anim
model
snp
immunerel
gene
encod
report
play
role
hcvrelat
infect
howev
role
hcv
infect
debat
inhibit
product
result
imbal
helper
respons
turn
lead
viral
persist
low
level
seem
associ
resolut
hcv
infect
convers
propos
antifibrogenet
chronic
liver
injuri
snp
osteopontin
opn
gene
associ
chronic
hcv
infect
respons
rate
higher
patient
gg
ga
allel
nt
comparison
patient
bear
aa
allel
likewis
respons
rate
higher
patient
tt
allel
nt
cc
ct
allel
opn
highli
phosphoryl
sialoprotein
import
compon
extracellular
matrix
secret
lymphocyt
leucocyt
macrophag
opn
interact
cellular
adhes
molecul
play
role
differ
aspect
cellular
immun
respons
exact
role
opn
hvc
infect
still
unclear
recent
studi
demonstr
associ
snp
exon
splice
acceptor
site
oligoadenyl
synthetas
gene
svr
hcv
patient
patient
exhibit
aa
genotyp
show
poor
svr
rate
progress
sever
diseas
import
protein
antivir
activ
activ
doublestrand
rna
upon
activ
inhibit
viral
rna
protein
synthesi
thu
nucleotid
chang
affect
function
expect
impair
viru
infect
control
importantli
snp
mannanbind
lectin
mbl
gene
also
known
mannos
bind
protein
relat
hcv
infect
hcv
patient
tend
exhibit
yayo
comparison
control
reduc
level
mlb
plasma
addit
frequenc
genotyp
reduc
patient
advanc
fibrosi
compar
patient
moder
fibrosi
mlb
pattern
recognit
receptor
prr
import
function
innat
immun
respons
nevertheless
role
hcv
control
well
known
anoth
host
factor
associ
hcv
infect
occurr
snp
promot
region
gene
also
known
type
iii
ifn
famili
includ
respect
base
molecular
structur
type
iii
ifn
belong
superfamili
function
close
relat
type
ifn
play
major
role
antivir
immun
produc
dendrit
cell
neuron
cell
alveolar
epitheli
cell
hepatocyt
respons
viral
infect
activ
via
tolllik
receptor
tlr
inhibit
viral
replic
modul
immunerel
function
matur
differenti
immun
cell
snp
recogn
strong
predictor
spontan
antiviralinduc
clearanc
hcv
sever
studi
shown
patient
infect
hcv
genotyp
bear
cc
aa
tt
allel
respect
like
achiev
svr
recent
discoveri
new
gene
within
type
iii
ifn
famili
situat
upstream
associ
poor
respons
therapi
impair
hcv
clearanc
suggest
complex
role
interferon
respons
hcv
infect
howev
arriv
second
third
gener
treatment
regimen
base
combin
differ
daa
without
ifn
downplay
relev
snp
predict
svr
track
hcv
infect
depend
sequenc
inform
origin
differ
subgenom
region
region
wide
use
detect
owe
degre
conserv
across
genotyp
region
common
target
hcv
genotyp
howev
two
region
well
conserv
therefor
contain
suffici
sequenc
inform
establish
genet
related
clinic
isol
instead
genet
related
studi
primarili
reli
inform
obtain
rapid
diverg
region
repres
challeng
molecular
epidemiolog
studi
result
loss
genet
link
relat
isol
sequenc
multipl
longer
subgenom
region
propos
altern
overcom
limit
impos
rapid
molecular
evolut
hcv
use
establish
related
among
hcv
case
use
gene
restor
link
isol
owe
lower
nucleotid
substitut
rate
despit
use
differ
subgenom
region
character
clinic
isol
whole
genom
sequenc
ultim
goal
hcv
molecular
epidemiolog
prior
implement
sophist
molecular
method
character
individu
variant
sscp
rel
popular
altern
approach
base
denatur
singlestrand
amplicon
resolv
nondenatur
condit
differenti
molecul
base
secondari
structur
popular
method
origin
base
assumpt
differ
variant
may
adopt
differ
secondari
structur
howev
sever
studi
show
implicit
limit
sscp
identif
close
genet
relat
variant
sensit
anoth
major
limit
sscp
variant
present
viral
popul
success
identifi
therefor
minor
variant
unlik
detect
addit
length
region
studi
impos
import
limit
long
fragment
may
resolv
clearli
shorter
fragment
factor
affect
perform
sscp
includ
dna
concentr
gc
content
despit
inexpens
rel
straightforward
approach
sscp
lack
requir
resolut
accur
assess
composit
hcv
intrahost
popul
thu
surpris
use
diminish
arriv
power
technolog
better
suit
demand
task
mani
way
heteroduplex
gel
shift
assay
resembl
sscp
therefor
benefit
disadvantag
two
method
rather
similar
overal
entir
intrahost
popul
sampl
howev
specif
inform
specif
substitut
popul
obtain
methodolog
base
amplif
hybrid
viral
rna
label
probe
next
heteroduplex
product
resolv
electrophoresi
thu
differ
variant
expect
exhibit
differ
migrat
pattern
due
mismatch
probe
result
differenti
band
profil
depend
composit
intrahost
popul
slight
variat
convent
heteroduplex
assay
reli
clone
differ
viral
speci
plasmid
instead
genet
differ
calcul
use
heurist
approach
known
heteroduplex
mobil
ratio
howev
accuraci
provid
method
limit
usual
requir
variant
differ
sequenc
individu
variant
cumbersom
costli
task
provid
import
inform
composit
intrahost
popul
basi
approach
includ
amplif
region
interest
follow
clone
amplicon
plasmid
vector
transform
bacteria
transform
bacteria
plate
bacteria
assum
carri
one
plasmid
presenc
one
viral
variant
sequenc
confirm
coloni
pcr
sequenc
thu
dna
individu
bacteri
coloni
repres
sequenc
singl
variant
unfortun
sampl
major
issu
particular
approach
even
larg
studi
analyz
hundr
clone
small
fraction
viral
popul
genom
sampl
moreov
exact
number
clone
necessari
achiev
given
level
confid
depend
frequenc
incorrect
nucleotid
given
nucleotid
posit
sequenc
suggest
clone
per
sampl
requir
frequenc
entropi
analys
sequenc
clone
propos
identifi
variant
present
frequenc
least
popul
howev
other
suggest
sequenc
clone
suffici
cover
major
variant
frequenc
popul
regardless
estim
circumst
minor
variant
go
undetect
significantli
hamper
capac
untangl
mechan
involv
hcv
evolut
recent
advanc
singl
genom
sequenc
improv
understand
hcv
transmiss
summari
regardless
number
clone
analyz
depth
popul
sequenc
assess
complex
hcv
intrahost
popul
extrem
limit
epldpcr
viabl
altern
singlemolecul
pcr
amplif
larg
use
identifi
individu
viral
variant
differ
virus
includ
human
immunodefici
viru
hiv
hepat
b
viru
hbv
hcv
epldpcr
reli
isol
individu
coexist
sequenc
variant
clinic
sampl
use
limitingdilut
approach
follow
sequenc
overal
epldpcr
less
prone
distort
compar
bacteri
cloningbas
method
amplif
base
singl
dna
molecul
moreov
realtimebas
epldpcr
shown
superior
convent
popul
sequenc
method
detect
hcv
viral
variant
howev
implement
epldpcr
cumbersom
time
consum
result
rather
expens
methodolog
ms
develop
altern
numer
dna
sequenc
technolog
origin
accuraci
sensit
highthroughput
methodolog
ms
set
basi
implement
molecular
method
aim
character
singl
nucleotid
chang
dna
molecul
ms
analysi
reli
measur
molecular
mass
differ
analyt
ioniz
separ
detect
unfortun
ioniz
may
lead
partial
degrad
analyt
therebi
affect
resolut
method
minim
effect
ioniz
analyt
method
matrixassist
laser
desorptionion
electrospray
ioniz
develop
ms
use
resequenc
microbi
type
singl
nucleotid
polymorph
discoveri
analysi
hcv
intrahost
popul
ms
report
ms
repres
highperform
methodolog
analyz
basespecif
cleav
rna
origin
pcr
fragment
costeffect
reproduc
approach
capabl
high
throughput
resolut
method
easili
accomplish
identif
nucleotid
polymorph
compris
amplicon
popul
data
origin
type
analysi
repres
composit
pattern
variant
present
sampl
importantli
identif
novel
singlenucleotid
variant
depend
proper
represent
variant
refer
databas
requir
base
call
therefor
constant
updat
refer
sequenc
requir
despit
implicit
advantag
msbase
approach
larg
use
assess
hcv
intrahost
popul
base
fact
de
novo
sequenc
challeng
also
arriv
power
inexpens
method
advent
ng
revolution
diagnost
infecti
diseas
develop
massiv
parallel
ultradeep
pyrosequenc
allow
highresolut
snapshot
intrahost
viral
popul
addit
newer
approach
overcom
issu
associ
short
read
result
longer
sequenc
facilit
reconstruct
viral
popul
ultradeep
sequenc
base
limit
dilut
approach
allow
rapid
sequenc
larg
number
variant
elimin
need
separ
molecul
clone
bacteri
vector
ultradeep
sequenc
use
identifi
minor
variant
differ
set
differ
platform
avail
includ
life
scienc
roch
illumina
ion
torrent
pacif
bioscienc
platform
initi
develop
altern
prohibit
expens
sanger
method
comprehens
character
viral
popul
easili
accomplish
ng
advantag
ng
technolog
virolog
numer
metagenom
grow
field
virolog
allow
character
viral
popul
differ
type
sampl
especi
detect
character
virus
associ
diseas
outcom
howev
overcom
differ
challeng
requir
implement
ng
approach
studi
viral
diseas
ng
amplicon
sequenc
allow
suffici
coverag
order
detect
variant
occur
frequenc
low
abund
nucleic
acid
major
problem
molecular
character
virus
clinic
sampl
low
ratio
viral
rnahost
rna
commonli
observ
clinic
sampl
one
main
obstacl
use
ng
method
preamplif
probe
captur
altern
avail
overcom
rel
low
frequenc
viral
rna
commonli
present
clinic
specimen
addit
viral
enrich
concentr
use
altern
method
improv
sequenc
qualiti
depth
nevertheless
whole
genom
wg
viral
sequenc
remain
challeng
analyt
sensit
wg
use
ng
approach
easi
evalu
larg
depend
depth
sequenc
howev
increas
depth
sequenc
optim
sampl
prepar
decreas
level
detect
moreov
analyt
sensit
depend
length
genom
longer
length
translat
higher
number
potenti
avail
read
seen
studi
virus
also
case
bacteri
fungal
genom
could
view
advantag
detect
microb
concentr
blood
low
even
sampl
infect
patient
sever
studi
evalu
diagnost
sensit
techniqu
analysi
human
virom
febril
afebril
children
allow
identif
wide
rang
virus
correl
outcom
diseas
well
viru
subtyp
anoth
advantag
techniqu
capac
identifi
coinfect
import
develop
adapt
therapeut
thu
ng
like
becom
routin
test
diagnost
infecti
diseas
initi
succeed
improv
sampl
prepar
avail
sequenc
central
laboratori
valid
pipelin
read
sort
taxonom
assign
must
attain
studi
viral
genet
era
next
gener
sequenc
promis
help
unveil
intim
detail
virushost
interfac
varieti
comput
challeng
commonli
encount
field
virolog
owe
high
divers
virus
compact
genom
organ
rapid
rate
evolut
hcv
increas
number
viral
sequenc
avail
public
privat
databas
promot
develop
novel
way
analyz
consider
larg
data
set
rel
recent
technolog
innov
ignit
explos
viru
genom
sequenc
like
help
us
understand
intim
detail
hcv
biolog
impact
public
health
nonetheless
benefit
deriv
gener
massiv
sequenc
data
hinder
implement
resourc
capabl
identifi
sequenc
well
assembl
annot
curat
maintain
store
extrem
larg
databas
importantli
virolog
recent
drawn
interest
bioinformat
commun
turn
led
develop
varieti
tool
rapid
expans
hcv
sequenc
univers
forc
recalibr
data
model
better
provid
extant
sequenc
represent
enhanc
refer
sequenc
product
serv
need
variou
viral
commun
howev
despit
growth
viral
bioinformat
number
question
remain
unansw
includ
restrict
identif
genom
annot
phylogeni
evolut
genet
divers
viral
evolut
mani
implic
clinic
virolog
emerg
hcv
resist
mutat
one
import
challeng
success
antivir
therapi
molecular
mechan
select
resist
mutat
complex
therefor
new
bioinformat
approach
character
hcv
evolut
intra
interhost
level
requir
integr
bioinformat
method
might
lead
predict
viral
evolut
hcv
chronic
patient
base
sequenc
deriv
intrahost
viral
popul
henc
ultim
goal
hcv
genet
predict
cours
hcv
evolut
turn
could
lead
custom
manag
patient
hepat
c
treatment
viral
phylogenet
also
benefit
exponenti
growth
bioinformat
phylogenet
import
area
virolog
particularli
hcv
molecular
epidemiolog
howev
sever
characterist
hcv
challeng
phylogenet
signific
differ
evolut
rate
high
short
term
much
lower
long
term
gene
transfer
evolutionari
virushost
relationship
lack
physic
fossil
record
virus
ancient
virus
remain
difficult
obstacl
overcom
addit
phylogenet
tree
deriv
hcv
sequenc
analys
faith
repres
complex
evolutionari
relationship
relev
hcv
horizont
gene
transfer
recombin
evolutionari
virushost
relationship
novel
phylogenet
approach
develop
recent
year
better
repres
relationship
howev
field
phylogenet
warrant
research
address
sever
aspect
relat
reconstruct
hcv
phylogeni
establish
time
infect
one
import
challeng
task
epidemiolog
investig
howev
infect
metric
among
case
multipl
risk
factor
possibl
exposur
difficult
pinpoint
therefor
determin
time
infect
use
molecular
data
repres
attract
line
research
estim
time
infect
base
pure
genet
data
report
howev
molecular
clock
estim
vari
significantli
reliabl
depend
number
factor
includ
sampl
tempor
anatom
distribut
sampl
genom
region
sequenc
super
reinfect
evolutionari
model
algorithm
use
consequ
implement
approach
genet
related
studi
undertaken
cautious
databas
collect
data
organ
content
easili
access
manag
updat
mani
databas
infecti
diseas
compil
data
obtain
clinic
andor
public
health
laboratori
aid
monitor
infecti
diseas
trend
surveil
howev
even
grow
abil
acquir
sequenc
data
potenti
impact
diseas
surveil
fulli
access
data
translat
public
health
action
initi
viral
bioinformat
resourc
center
vbrc
aim
close
gap
massiv
viral
sequenc
bioinformat
welcom
addit
set
onlin
bioinformat
tool
avail
scientif
commun
tool
provid
comprehens
webbas
genom
resourc
use
basic
appli
virolog
research
vbrc
consist
relat
databas
web
applic
data
storag
annot
analysi
inform
exchang
curat
data
result
abil
search
gene
function
relat
biolog
genotyp
phenotyp
emphasi
pathogenesi
provid
varieti
analyt
visual
tool
hcv
databas
project
initi
fund
divis
microbiolog
infecti
diseas
nation
institut
allergi
infecti
diseas
niaid
hcv
databas
resourc
scientif
commun
work
hcv
genet
evolut
variabl
vaccin
drug
design
hcv
sequenc
deposit
genbank
compos
backbon
databas
includ
inform
countri
sampl
year
isol
name
genotyp
subtyp
host
speci
addit
relev
annot
inform
associ
correspond
public
annot
field
databas
includ
genotyp
subtyp
start
stop
coordin
rel
refer
strain
hcvh
sampl
countri
sampl
citi
sampl
date
sampl
tissu
patient
inform
also
document
databas
includ
health
statu
age
gender
alt
level
treatment
result
coinfect
hiv
hepat
b
infect
date
infect
countri
infect
citi
infect
rout
infect
outcom
hla
type
epidemiolog
relationship
patient
hcv
databas
contain
hcvassoci
handannot
genet
data
provid
access
central
databas
via
webaccess
search
interfac
addit
number
analysi
tool
lo
alamo
hcv
databas
emerg
result
success
hiv
databas
group
use
similar
approach
infrastructur
develop
dynam
align
larg
number
sequenc
hiv
databas
quickli
implement
hcv
databas
tool
design
manipul
viral
sequenc
gene
extract
coordin
refer
strain
sequenc
align
nucleotid
protein
motif
scan
easili
adapt
hcv
databas
inform
access
via
interfac
allow
advanc
search
sort
graphic
overview
capabl
importantli
sequenc
data
retriev
dna
align
premad
manual
optim
align
also
provid
varieti
flavor
synonymousnonsynonym
substitut
analysi
gene
protein
avail
geographi
tool
plot
genotyp
frequenc
base
geograph
origin
function
includ
glycosyl
site
identif
modeltest
treemak
blast
pcoord
gene
cutter
consensu
peptgen
motiscan
primalign
epilign
seqconvert
omniread
seqpublish
sequenc
locat
unfortun
valuabl
resourc
longer
fund
nih
therefor
herculean
effort
properli
maintain
significantli
delay
lack
financi
support
viru
pathogen
databas
analysi
resourc
vipr
support
virolog
research
studi
select
agent
signific
public
health
pathogen
belong
viru
famili
includ
hcv
crossreferenc
data
integr
comput
tool
onlin
vipr
resourc
allow
complex
analys
vipr
captur
data
extern
intern
sourc
make
access
custom
search
vipr
primarili
focus
virus
human
interest
howev
famili
isol
host
speci
also
avail
comparison
vipr
featur
suit
data
analysi
visual
tool
perform
custom
correl
analys
vipr
use
ncbi
refseq
strain
extend
manual
optim
annot
rest
taxon
thu
vipr
resourc
provid
scientif
commun
friendli
tool
capabl
perform
complex
analyt
workflow
importantli
requir
establish
databasetyp
molecular
surveil
network
feasibl
intern
surveil
network
standard
input
data
sever
initi
involv
intern
partnership
pilot
studi
initi
array
pathogen
includ
hcv
data
share
critic
interdisciplinari
approach
order
tackl
problem
introduct
ng
routin
diagnost
like
boost
hcv
integr
surveil
appli
analyt
tool
genom
data
hcv
public
health
scientist
track
specif
mutat
confer
abil
resist
drug
link
transmiss
network
howev
inform
provid
raw
genom
sequenc
pathogen
must
integr
knowledg
host
biolog
well
societ
environment
factor
order
understand
etiolog
epidem
anticip
trajectori
therefor
develop
diagnost
pipelin
critic
reli
databas
exhaust
match
rapid
growth
databas
prompt
ng
typic
blast
analysi
million
sequenc
de
novo
assembl
larger
contig
whole
ncbi
databas
use
relax
criteria
time
resourceconsum
diagnost
contrast
stringent
map
nonassembl
read
comprehens
databas
conjunct
long
sequenc
read
like
improv
overal
process
thu
hcv
integr
molecular
surveil
tool
ideal
webbas
includ
viral
host
factor
well
epidemiolog
data
figur
addit
intern
public
privat
sequenc
databas
ideal
hcv
integr
databas
enrich
data
obtain
ongo
molecular
surveil
project
outbreak
investig
supplement
possibl
sequenc
inform
case
identifi
hepat
clinic
blood
bank
result
comprehens
analys
includ
human
genet
phylogenet
data
mine
could
easili
attain
local
research
field
minim
effort
afford
cost
local
state
public
health
laboratori
figur
data
mine
knowledg
discoveri
databas
interdisciplinari
subfield
comput
scienc
refer
comput
process
discov
pattern
larg
dataset
via
artifici
intellig
machin
learn
statist
databas
system
ultim
goal
data
mine
analysi
tremend
volum
data
discov
hidden
pattern
relationship
highli
complex
dataset
render
valuabl
inform
attain
seri
data
preprocess
model
infer
consider
interesting
metric
complex
consider
postprocess
discov
structur
visual
process
applic
machin
learn
method
advanc
statist
model
laboratori
data
subsequ
discoveri
pattern
relev
identif
factor
associ
diseas
outcom
hcv
infect
decisiontre
analysi
core
compon
data
mine
analysi
use
build
predict
model
therapeut
outcom
antivir
therapi
chronic
hcv
patient
sever
diseas
decisiontre
analysi
reli
treeshap
structur
repres
decis
call
classifi
power
intern
node
denot
attribut
branch
repres
outcom
test
termin
node
class
decisiontre
analysi
facilit
classif
patient
subgroup
identifi
possibl
outcom
hcv
therapi
therebi
improv
diagnost
approach
linear
progress
bayesian
network
analys
also
shown
produc
robust
predict
progress
fibrosi
interestingli
hcv
epistasi
strongli
associ
host
factor
suggest
intrahost
viral
evolut
converg
import
trait
model
result
predict
clinic
relev
hcv
molecular
evolut
mani
way
affect
viru
spread
diseas
transmiss
sophist
achiev
hcv
shape
molecular
evolutionari
pattern
intric
significantli
hinder
abil
fulli
understand
mechan
exploit
viru
ensur
transmiss
remark
hcv
mutat
rate
repres
challeng
task
molecular
epidemiolog
new
era
advanc
sequenc
technolog
implement
enhanc
molecular
surveil
utmost
import
order
accur
monitor
circul
viral
strain
comprehens
molecular
studi
requir
uncov
key
particip
element
respons
virul
supplement
molecular
data
epidemiolog
inform
host
factor
significantli
improv
accuraci
hcv
molecular
surveil
therefor
fact
comprehens
epidemiolog
investig
must
carri
underst
improv
assess
hcv
intrahost
genet
variabl
clarifi
pathway
toward
advanc
integr
molecular
surveil
ultim
help
unveil
mechan
drive
viral
transmiss
advanc
molecular
surveil
truli
effect
implement
prevent
control
measur
along
therapeut
intervent
perform
past
year
sinc
discoveri
hcv
quit
journey
futur
hcv
control
look
promis
ever
